Heads have turned in biotech circles with an ASX filing confirming that Platinum Asset Management has increased its stake in clinical-stage drug developer Syntara to 19.24%, fresh off the commencement of a Phase 2a clinical study that has the potential to become a new treatment for patients diagnosed with myelofibrosis (bone marrow cancer). The combination
Read More
It is not just a tough environment for job seekers but also for job portals like SEEK (ASX: SEK), which are grappling with lowered ad revenue. In H1 FY24, SEEK reported a 5% decline in revenue compared to H1 FY23, totaling $596.8 million. EBITDA saw an 11% decline to $252.9 million, while net profit after
Read More
As more Aussies turn to streaming services, traditional TV networks like Seven West Media (ASX: SWM) are facing tough times. Less people are watching TV, which means less money spent on ads, hitting Seven’s finances hard. Last year, Australian TV ads dropped by 8%, while the total TV market declined by 9%, reflecting the trend
Read More
The XJO is expected to edge higher on open this morning despite a small pullback in the U.S overnight. Their futures have also edged into the red. The sidewards consolidation continues as we track around 6,950. Key support remains 7,550, and key resistance remains roughly 7,700. It seems markets are quiet heading into the CPI
Read More
War may be ravaging through parts of the Middle East and Ukraine, prompting many contract wins over the past 12 months but that hasn’t translated into profit for body armour and ballistics manufacturer HighCom (ASX: HCL) which has confirmed large losses are now anticipated. The profit downgrade, which HighCom announced after the market closed on
Read More
In a much-needed and laudable development for women’s healthcare in Saudi Arabia, medical devices company TruScreen’s (ASX: TRU) distributor, Bettalife, has successfully obtained reimbursement approval from the majority of private health insurance companies in the country. With reimbursement in place, women who are insured and opt for TruScreen over the conventional Pap Smear will receive
Read More